IPO Roundup: A $1B German biotech and an Illinois-based bank set to go public this week

BioNTech SE would be the third-largest development-stage biotech to list in the US at its projected IPO price

Nasdaq building
BioNTech SE is developing individualized immunotherapies to treat cancer

Two companies are expected to debut on the Nasdaq this week, each planning to command a nine-figure IPO.

BioNTech SE (NASDAQ:BNTX), a German biotechnology company developing individualized immunotherapies to treat cancer, plans to raise $251 million in its IPO. The company is set to offer 13.2 million shares at a price between $18 and $20 per share.

An IPO of that size would give the company a market cap of $4.45 billion and make it the third-largest development-stage biotech to list in the US, according to broker Renaissance Capital.

Founded in 2008, the company has a drug pipeline of more than 20 product candidates, seven of which have entered into eight clinical trials.

HBT Financial Inc (NASDAQ:HBT), a bank holding company based in Bloomington, Illinois, hopes to raise $149 million by offering 8.3 million shares at a price between $17 and $19 per share. 

As of June 30, HBT had total assets of $3.2 billion. It had loans held for investment of $2.2 billion, total deposits of $2.8 billion and stockholders' equity of $340 million.

Its bank subsidiaries, Heartland Bank and Lincoln Bank, operate 64 branches in central and northeastern Illinois. 

HBT Financial was formerly known as Heartland Bancorp.

Contact Andrew Kessel at [email protected] 

Follow him on Twitter @andrew_kessel

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Buds & Duds: Ontario's cannabis retail expansion plan gives cannabis stocks...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, was 1.4% higher at 116.7 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF jumped 2.4% at C$9.55, while the OTCQX Cannabis index gained 0.6% to 434 points. Buds today are The Green...

1 day, 8 hours ago

2 min read